A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin
- 1 September 1997
- journal article
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 35 (9) , 903-907
- https://doi.org/10.1016/s0278-6915(97)00066-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Nomenclature for human CYP2D6 allelesPharmacogenetics, 1996
- The management of renal cell carcinomaCritical Reviews in Oncology/Hematology, 1994
- Metabolism of [3-14C] coumarin by human liver microsomesXenobiotica, 1994
- Interindividual variability of coumarin 7-hydroxylation in healthy volunteersPharmacogenetics, 1992
- Metabolism of [3-14C]coumarin to polar and covalently bound products by hepatic microsomes from the rat, syrian hamster, gerbil and humansFood and Chemical Toxicology, 1992
- Phase II evaluation of coumarin (1,2‐benzopyrone) in metastatic prostatic carcinomaThe Prostate, 1992
- A synopsis of the unconjugated acidic transamination metabolites of phenylalanine in phenylketonuriaJournal of Inherited Metabolic Disease, 1991
- The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomesBiochemistry, 1990
- Comparison of the metabolism and disposition of [3-14C]coumarin in the rat and marmoset (Callithrix jacchus)Toxicology Letters, 1989
- Metabolism of Coumarin in ManNature, 1969